Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (438)	12/8/2003 10:42:52 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NVS Doesn't seem inclined to close any of its recent upgaps.<g> It had an upgap on November 14 and another one on November 26.Today it is trading to the upside and seems ready to test its July 2002 H of 43.40 (The recent December 3 H remained a little below it at 43.38 <g>) On closing above that level it seems that it should be able to deal with the January 2001 H at 45.15 <g> NVS announced today that patients with CML and Ph+ had a better response by doubling the dose of Gleevec from 400 mgs/day to 800 mgs/day. bigcharts.marketwatch.com bigcharts.marketwatch.com Bernard